Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 200000-59-5 | MDL No. : | MFCD13183777 |
Formula : | C27H26F7NO5S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SQSDKFVTNMLFGV-YNXGUESPSA-N |
M.W : | 609.55 | Pubchem ID : | 11592498 |
Synonyms : |
|
Num. heavy atoms : | 41 |
Num. arom. heavy atoms : | 18 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 13.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 137.93 |
TPSA : | 93.24 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.54 cm/s |
Log Po/w (iLOGP) : | 3.31 |
Log Po/w (XLOGP3) : | 3.49 |
Log Po/w (WLOGP) : | 9.65 |
Log Po/w (MLOGP) : | 4.98 |
Log Po/w (SILICOS-IT) : | 5.83 |
Consensus Log Po/w : | 5.45 |
Lipinski : | 2.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 1.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.17 |
Log S (ESOL) : | -5.68 |
Solubility : | 0.00127 mg/ml ; 0.00000209 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.13 |
Solubility : | 0.00451 mg/ml ; 0.0000074 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -7.47 |
Solubility : | 0.0000207 mg/ml ; 0.0000000339 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 4.95 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 31599-68-5 ]
2-(3-(Trifluoromethyl)phenyl)morpholine hydrochloride
Similarity: 0.54
[ 143062-84-4 ]
(1R,2S)-2-Fluorocyclopropanamine 4-methylbenzenesulfonate
Similarity: 0.51
[ 1391469-10-5 ]
(S)-3-(4-Fluorophenyl)morpholine hydrochloride
Similarity: 0.50
[ 77497-97-3 ]
Benzyl (S)-(-)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylate p-Toluenesulfonic Acid Salt
Similarity: 0.69
[ 384338-21-0 ]
1-Benzyl-4-methylpiperidin-3-ol 4-methylbenzenesulfonate
Similarity: 0.59
[ 111769-27-8 ]
(R)-Tetrahydrofuran-3-amine 4-methylbenzenesulfonate
Similarity: 0.57
[ 1965314-51-5 ]
(R)-Methyl 2-(pyrrolidin-3-yloxy)acetate 4-methylbenzenesulfonate
Similarity: 0.57
[ 153086-37-4 ]
3-(Dipropylamino)-4-methoxybenzenesulfonic acid
Similarity: 0.53
[ 31599-68-5 ]
2-(3-(Trifluoromethyl)phenyl)morpholine hydrochloride
Similarity: 0.54
[ 384338-21-0 ]
1-Benzyl-4-methylpiperidin-3-ol 4-methylbenzenesulfonate
Similarity: 0.59
[ 111769-27-8 ]
(R)-Tetrahydrofuran-3-amine 4-methylbenzenesulfonate
Similarity: 0.57
[ 1965314-51-5 ]
(R)-Methyl 2-(pyrrolidin-3-yloxy)acetate 4-methylbenzenesulfonate
Similarity: 0.57
[ 23735-43-5 ]
(S)-(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate
Similarity: 0.54
[ 23788-74-1 ]
(R)-(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate
Similarity: 0.54
[ 31599-68-5 ]
2-(3-(Trifluoromethyl)phenyl)morpholine hydrochloride
Similarity: 0.54
[ 1185045-95-7 ]
3-(4-Fluorophenyl)morpholine hydrochloride
Similarity: 0.50
[ 1363408-43-8 ]
(R)-3-(4-Fluorophenyl)morpholine hydrochloride
Similarity: 0.50
[ 1391469-10-5 ]
(S)-3-(4-Fluorophenyl)morpholine hydrochloride
Similarity: 0.50